News Center



14

2022

-

10

Warm congratulations to Caremo Pharmaceutical on the successful acceptance of its Biosafety Level 2 (BSL-2) Microbiology Laboratory!


Recently, the expert team of Nanjing Commission of Health carried out on-site verification, evaluation and acceptance of Caremo microbiology laboratory. After comprehensive evaluation of laboratory personnel, equipment, reagents and consumables, and environment, the expert team listened to the on-site report of Caremo. After detailed verification and inspection, it was confirmed that microbiology laboratory of Caremo meets the requirements of biosafety laboratory level 2.

As an integral component of Caremo's preclinical drug research center, the successful certification of this microbiology laboratory signifies full recognition of the company's microbial testing capabilities and quality management system. This achievement further enhances Caremo's competitiveness in preclinical drug research services.

The laboratory has now fully commenced microbial testing operations, including:

  • Cell-level screening and pharmacodynamic studies
  • Drug genotoxicity research
  • Microbial characterization studies
  • Bactericidal/bacteriostatic efficacy testing

 · Example Experiment:Antimicrobial Susceptibility Testing (AST) - Minimum Inhibitory Concentration (MIC) Method

Related news

HAPPY CHINESE NEW YEAR !

2026-02-16

The 2025 Annual Commendation Ceremony of Comer Pharmaceuticals was successfully concluded!

2026-02-10

2026: Steadfast and Unwavering, Moving Forward with Conviction

2026-01-01

2026: Steadfast and Unwavering, Moving Forward with Conviction

2026-01-01

Copyright © Nanjing Caremo Biomedical Co., Ltd.

苏公网安备32011302321466号

本网站已支持IPV4 / IPV6 双向访问